SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

YoCrunch yogurt products are being pulled from store shelves nationwide due to a safety concern -- plastic in the dome -- its ...

Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in ...

Lumos Diagnostics signs exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of FebriDX in US.

I am a 75-year-old woman who isn’t prediabetic or diabetic. My BMI is 31.2. My doctor has prescribed a trial of metformin for ...

Health and Human Services Secretary Robert F. Kennedy Jr. lambasted federal agencies he accused of being overly influenced by ...

While we believe pricing pressure will persist across some of Hologic’s products, we forecast gross margins to hover around 59% through fiscal 2029 as the firm increases its recurring revenue of ...

COVID-19 cases are on the rise again across the United States, with the biggest increases in parts of the South, Southeast ...

Does colchicine work for CVD or doesn’t it? That’s the question the study authors hoped to answer, but there’s little ...

California Creates Housing Agency: After years of soaring rents, increasingly out-of-reach home prices and an enduring homelessness crisis that touches every corner of the state, California is finally ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.